In April 2023, CCSRMB I closed the first RMB denominated GP-led transaction involving a portfolio of high quality healthcare assets. The transaction’s total size was approximately RMB 315m.
In December 2022, CCO I agreed to acquire a $40m position in a 2017 vintage fund with a focus on US and European mezzanine investments from Cathay Life, a large Asian life insurance company.
In July 2022, CIP VIII co-lead the largest GP-led transaction in Asia with Hahn & Company for SsangYong C&E, closing at approximately $1.5bn. Coller Capital and its co-investors were the single largest investors.
In July 2021 CIP VIII's investment and co-investment vehicles led the world’s largest private credit secondaries transaction for a $680 million credit portfolio, managed by Ping An Overseas Holdings.
In May 2021, CIP VIII co-led a GP-led process where a portfolio of healthcare assets were moved from Legend Capital’s Fund V and VI into a continuation fund, with $270 million in aggregate commitments.
In December 2020, CIP VIII co-led a GP-led process whereby Hightower Advisors, a Chicago-headquartered wealth advisory business, was moved from 2016-vintage Thomas H Lee VII to a single-asset continuation vehicle. The transaction allowed the GP to provide a liquidity option to its LPs whilst being able to hold onto a well-performing asset for longer.
In May 2020, CIP VIII led a GP-led secondary transaction for Permira IV. The fund’s four assets, together with a co-investment for the largest asset, were transferred into a new investment vehicle with $829 million of aggregate commitments.
In December 2019, CIP VIII backed, with a $222m commitment, a single-asset GP-led transaction whereby Action, a fast-growing European non-food discount retailer, was moved from 3i Eurofund V to a continuation vehicle. The transaction facilitated a liquidity offering to existing LPs, while allowing the GP to continue their successful rollout of Action stores throughout Europe. This transaction was awarded European deal of the year in 2020 by Private Equity International.
In November 2019 CIP VII led a transaction, with a $120m commitment, whereby Upstream Rehabilitation (the third-largest operator of outpatient physical therapy clinics in the US), was moved from a 2015-vintage buyout fund to a new single-asset vehicle. The process allowed Revelstoke Capital Partners to hold its top-performing asset longer to maximise value and to offer a liquidity option to existing LPs.
In June 2019, CIP VIII agreed to acquire a $500m portfolio of 142 LP positions across eight private and listed fund-of-funds vehicles managed by Aberdeen Standard Investments (‘ASI’). The deal represented the seventh successfully completed transaction with the ASI team
In April 2019 CIP VII made an investment in an Australian education business via a continuation vehicle managed by Baring Private Equity Asia. The asset was transferred from Baring’s 2007-vintage Fund VI.
In January 2019, CIP VII underwrote a new fund arrangement with Investcorp, in relation to six assets from its European private equity portfolio. The fund will be capitalised with approximately US$1bn million of aggregate commitments, with Investcorp retaining a continued interest in the portfolio through a meaningful GP commitment to the fund.
In April 2018, CIP VII signed an agreement with CDC Group, the UK government’s development finance institution, to commit up to $300m to pursue secondary opportunities in India-focused private equity funds. The transaction combines CDC’s deep knowledge of the Indian market with Coller Capital’s expertise in complex investments and innovative transaction structures. In May 2018 the partnership closed on its first transaction, the $98m GP-led secondary investment in a 2008-vintage India-focused fund.
In 2018, CIP VII led the world’s largest GP-led transaction of its time: a liquidity offer made for €2.2bn to Nordic Capital investors.
In March 2018, CIP VII acquired 45 LP positions, totalling $350m, from Aberdeen Private Equity Funds Limited.
In July 2017 CIP VII invested £125m into the public to private acquisition of Shawbrook Bank by Pollen Street Capital and BC Partners.
In August 2016, CIP VII acquired a $257m portfolio of senior secured loans managed by Northport Capital. The team was spun out into CVC’s direct lending platform.
In July 2016, CIP VI and CIP VII committed $288m to a GP-led transaction: a liquidity offer made to J C Flowers investors.